Systemic inhibition of PTPN22 augments anticancer immunity
Won Jin Ho(Johns Hopkins University), Elizabeth M. Jaffee(Bloomberg (United States))
Cited by 52
Related Papers
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients
|The Journal of Experimental Medicine|2004|349
Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study)
|Clinical Cancer Research|2019|260
Future cancer research priorities in the USA: a Lancet Oncology Commission
|The Lancet Oncology|2017|209
Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors
|Journal of Clinical Oncology|2023|193